A comprehensive longitudinal analysis of individuals with preclinical Huntington’s disease identifies biomarkers of neurodegeneration and somatic expansion in blood DNA, detectable years before symptom onset.
- Rachael I. Scahill
- Mena Farag
- Sarah J. Tabrizi